We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 01/9/2020 09:15 | Section L13 on the techatlas: | wetdream | |
| 01/9/2020 08:50 | Kevzara is a treatment 🙄🙄&# | d1nga | |
| 01/9/2020 08:41 | I think that's what he's saying - that with vaccines failing, a treatment is more important than ever? | sloppyjoe2 | |
| 01/9/2020 08:33 | It's a treatment not a vaccine!!! | nobbygnome | |
| 01/9/2020 08:22 | Vaccine failure, treatment more important than ever........Major pharmaceutical companies abandon trials for COVID-19 vaccine A POTENTIAL coronavirus vaccine has failed in clinical trials after the latest set of results showed the drug, Kevzara, to show adverse effects on patients.The potential vaccine, which is produced by Sanofi and Regeneron, will cease to continue with the drug after failing COVID-19 treatment trials. | buddy one |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
